DyGeDem: Demographic Characteristics and Psychosocial Health of Transgender People
Sponsor
Central Hospital, Nancy, France (Other)
Overall Status
Unknown status
CT.gov ID
NCT04554849
Collaborator
(none)
320
1
17.3
18.5
Study Details
Study Description
Brief Summary
To study demographic characteristics of subjects referred to endocrine care for gender dysphoria and their psychosocial health
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Study Design
Study Type:
Observational
Anticipated Enrollment
:
320 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Demographic Characteristics and Psychosocial Health of Transgender People
Actual Study Start Date
:
Jul 24, 2020
Anticipated Primary Completion Date
:
Jan 1, 2022
Anticipated Study Completion Date
:
Jan 1, 2022
Outcome Measures
Primary Outcome Measures
- Retrospective analysis of medical records [2004-2020]
Analysis of existing data
Eligibility Criteria
Criteria
Ages Eligible for Study:
N/A
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion criteria - Person having received complete information on the organization of the research and willing to participate to research
Exclusion criteria:
- lack of data in the patients' records
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | CHRU Nancy | Nancy | France | 54000 |
Sponsors and Collaborators
- Central Hospital, Nancy, France
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Central Hospital, Nancy, France
ClinicalTrials.gov Identifier:
NCT04554849
Other Study ID Numbers:
- 2020PI158
First Posted:
Sep 18, 2020
Last Update Posted:
Sep 18, 2020
Last Verified:
Jul 1, 2020
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms: